[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.150.215. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 68
Citations 0
Correspondence
Mar 2012

Gabapentin Not Shown to Prevent Postherpetic Neuralgia —Reply

Author Affiliations

Author Affiliations: Department of Dermatology, The Marshfield Clinic, Marshfield, Wisconsin.

Arch Dermatol. 2012;148(3):401-402. doi:10.1001/archdermatol.2011.2870

In reply

Dr Fett brings up valid points that relate to promoting the herpes zoster vaccine, which has randomized controlled trials supporting its use in preventing PHN.1 We do not mean to suggest an opposition to this prevention strategy. Unfortunately, most individuals indicated to receive the herpes zoster vaccine fail to receive their vaccination to prevent herpes zoster. This is a very worthy practice gap with several barriers and strategies worth exploring, but this topic was beyond the scope of our limited commentary. Unfortunately, in this large unvaccinated population (and even in the vaccinated population), zoster still occurs. We maintain that the best available evidence now supports the use of gabapentin in otherwise healthy patients older than 50 years with herpes zoster who report a pain score greater than 5 of 10.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×